ATE237319T1 - Transdermales system enthaltend nicht- steroidische entzündungshemmer in einer acrylpolymer-klebematrix - Google Patents

Transdermales system enthaltend nicht- steroidische entzündungshemmer in einer acrylpolymer-klebematrix

Info

Publication number
ATE237319T1
ATE237319T1 AT00906508T AT00906508T ATE237319T1 AT E237319 T1 ATE237319 T1 AT E237319T1 AT 00906508 T AT00906508 T AT 00906508T AT 00906508 T AT00906508 T AT 00906508T AT E237319 T1 ATE237319 T1 AT E237319T1
Authority
AT
Austria
Prior art keywords
adhesive matrix
inflammatory
acrylic polymer
system containing
containing non
Prior art date
Application number
AT00906508T
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Alejandro Fabio Scasso
Roberto Juan Gabach
Original Assignee
Amarin Technologies S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Technologies S A filed Critical Amarin Technologies S A
Application granted granted Critical
Publication of ATE237319T1 publication Critical patent/ATE237319T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00906508T 1999-03-01 2000-02-29 Transdermales system enthaltend nicht- steroidische entzündungshemmer in einer acrylpolymer-klebematrix ATE237319T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AR9900866 1999-03-01
PCT/GB2000/000707 WO2000051575A1 (en) 1999-03-01 2000-02-29 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix

Publications (1)

Publication Number Publication Date
ATE237319T1 true ATE237319T1 (de) 2003-05-15

Family

ID=3461151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906508T ATE237319T1 (de) 1999-03-01 2000-02-29 Transdermales system enthaltend nicht- steroidische entzündungshemmer in einer acrylpolymer-klebematrix

Country Status (8)

Country Link
EP (1) EP1158967B1 (de)
AT (1) ATE237319T1 (de)
AU (1) AU2816700A (de)
BR (1) BR0008640A (de)
CA (1) CA2366852A1 (de)
ES (1) ES2197077T3 (de)
MX (1) MXPA01008785A (de)
WO (1) WO2000051575A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
EP1061900B2 (de) 1999-01-14 2008-07-09 Noven Pharmaceuticals, Inc. Dermale zusammensetzungen
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
US20040127531A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Adhesive coated sheet for dermal delivery of a selective cyclooxygenase-2 inhibitor
US20040126415A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
GB0524958D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
JP5285279B2 (ja) * 2005-12-28 2013-09-11 久光製薬株式会社 経皮吸収型製剤
JPWO2009031318A1 (ja) * 2007-09-05 2010-12-09 興和株式会社 鎮痛・抗炎症剤含有外用剤
EP2055298A1 (de) * 2007-10-30 2009-05-06 Novartis AG Topische Zusammensetzung
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
AU2015313842A1 (en) 2014-09-10 2017-03-30 Novartis Consumer Health S.A. Topical diclofenac sodium compositions
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
WO1994015609A1 (en) * 1992-12-31 1994-07-21 Sunkyong Industries Co., Ltd. Enhanced pharmaceutical compositions for skin penetration
WO1994023713A1 (en) * 1993-04-22 1994-10-27 Minnesota Mining And Manufacturing Company Transdermal antiinflammatory composition
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac

Also Published As

Publication number Publication date
EP1158967B1 (de) 2003-04-16
EP1158967A1 (de) 2001-12-05
AU2816700A (en) 2000-09-21
MXPA01008785A (es) 2003-07-14
CA2366852A1 (en) 2000-09-08
BR0008640A (pt) 2001-12-18
WO2000051575A1 (en) 2000-09-08
ES2197077T3 (es) 2004-01-01

Similar Documents

Publication Publication Date Title
ATE237319T1 (de) Transdermales system enthaltend nicht- steroidische entzündungshemmer in einer acrylpolymer-klebematrix
HUP0103715A2 (hu) Topikus tapasz savcsoportot tartalmazó nemszteroid reumaellenes hatóanyaggal
KR960700060A (ko) 활성 성분으로서 갈린타민을 함유한 경피 치료 시스템(transdermal therapeutic system with galanthamine as active ingredient)
ATE136576T1 (de) Durch wasser inaktivierbarer, druckempfindlicher klebstoff
ATE196843T1 (de) Estradiolhaltiges transdermales therapeutisches system
DE59506370D1 (de) Estradiolhaltiges pflaster
BR0211993A (pt) Sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais
BR0010618A (pt) Sistema terapêutico transdermal (tts), que contém tolterodina
DE60028256D1 (de) Druckempfindliche klebstoffe und sternblockpolymere und acrylpolymere enthaltende gegenstände
EP2204181A3 (de) Protease-Hemmer
ES2114157T3 (es) Copolimeros de (met)acriloxi-alquil-siloxisilano y alquil(met)acrilatos y su uso como adhesivos sensibles a la presion.
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
NZ502351A (en) Transdermal therapeutical system for delivery of levonorgestrel
CA2335582A1 (en) Transdermal therapeutic system containing hormones and crystallization inhibitors
AU2001240551A1 (en) Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
DK0474647T3 (da) Fremgangsmåde og indretning til frigivelse af lægemidler til huden
AU8197901A (en) Matrix controlled transdermal system for stabile derivatives of ace inhibitors
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
PT1011674E (pt) Sistema terapeutico transdermico com a substancia activa escopolamina base
KR100996841B1 (ko) 부착제
WO2001036557A3 (en) Adhesive
ES2141548T3 (es) Preparado farmaceutico de superficie estabilizada para su aplicacion sobre la piel.
FR2246616A1 (en) Ethylene-vinyl acetate copolymer coated self-adhesive tape - contg (meth)acrylate esters of polyhydric alcohols
WO2003097008A3 (en) Transdermal delivery device for the administration of fentanyl

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties